What You Should Know:
BioIntelliSense, a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health, announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and…
Continue Reading
MD Anderson’s Institute for Data Science in Oncology (IDSO) pioneers a transformative approach. Collaborating across disciplines, it leverages advanced data science and clinical expertise to drive impactful cancer care innovations. By analyzing vast data…
Continue Reading
What You Should Know:
– Aranscia, a global provider of diagnostics software, services, and testing solutions, has acquired select assets of the YouScript personalized medication management platform from Invitae Corporation in an all-cash transaction.
– YouScript…
Continue Reading
By Hannah Nelson
November 16, 2023 – Several healthcare organizations have recently selected the CommunityWorks EHR from Oracle Health to enhance operational workflows.
The platform aims to support the clinical, financial, and operational needs of smaller…
California-based Carrum Health, a digital marketplace allowing employers to purchase bundled healthcare services, announced in September that it joined the White House-led Cancer Moonshot CancerX initiative, uniting with cross-disciplinary stakeholders to drive innovation in…
Continue Reading
What You Should Know:
– Emory University has launched the Emory Empathetic AI for Health Institute as part of its AI.Humanity initiative to leverage AI and big data to transform healthcare globally.
– The institute aims…
Continue Reading
My phone chimed with a notification, signaling the availability of a new CT test result in my online health portal. “Multiple bilateral pulmonary nodules measuring up to 8mm. May represent metastatic disease.”
This was several…
What You Should Know:
– Health Catalyst has acquired Electronic Registry Systems, Inc. (ERS), a prominent cancer registry software and services provider. Financial details of the acquisition were not disclosed.
– The acquisition aims to strengthen…
Continue Reading
Dr. Howard Sandler, the ASTRO president, spotlights personalized patient care through advanced imaging and bespoke radiation therapies. He emphasizes strides in the PACE-B trial’s ultrashort regimens and champions workforce diversity and equitable patient representation…
Continue Reading
GE HealthCare’s AI can accurately predict patient responses to immunotherapy, as demonstrated in collaborative studies with VUMC and UME. The models, showcasing 70-80% accuracy, may guide more personalized treatment decisions, potentially minimizing side effects…
Continue Reading
